Merck Ventures
Adherence Healthcare Prevention

Business Overview

We drive innovation and back entrepreneurs through equity investments and hands on support in fields that could impact the vitality and sustainability of Merck KGaA, Darmstadt, Germany’s current and future businesses.

We are the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany. Our mandate is to invest in innovative technologies and products with the potential to significantly impact Merck KGaA, Darmstadt, Germany’s core business areas. From our headquarters in Amsterdam and Darmstadt and offices in Germany, Israel and the US we invest globally in transformational ideas driven by great entrepreneurs. We take an active role in our portfolio companies and team up with entrepreneurs and co-investors to translate innovation towards commercial success. We have a significant focus on early stage investing and company creation including the creation of spin-offs to leverage Merck KGaA, Darmstadt, Germany’s science and technology base.

The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck KGaA, Darmstadt, Germany’s business areas, though formally separated by a “Chinese Wall”. The total volume of the corporate venture fund is € 400 million.

We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.

The Healthcare team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck KGaA, Darmstadt, Germany and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.

The Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R&D center.

We invest globally in emerging performance materials companies that develop high-tech chemicals for sophisticated applications. Specialty chemicals, such as liquid crystals for displays, pigments for coating and cosmetics, or high-tech materials for the electronics industry. The Performance Materials team helps driving better solutions for our customers.

We invest globally in emerging life science companies that develop products, services and or technologies that have the potential to make research and biotech production easier, faster, more successful and enhance customer service. The Life Science team manages helps driving better solutions for our customers.

Investor type
Corporate Venture Capital
Business model preference
B2B, B2B2C, B2C
Series preference
Series B
Capital raised
$485,000,000
Offering preference
Software
AI type preference
Artificial Intelligence
Sectors
Adherence Healthcare Prevention

Team

Merck Ventures
Jasper Bos
Managing Director

Investment Portfolio

Startup

Operating Status

Offering Type

Business Model

Total Funding

AI Employees

Feelit
Active
Hardware, Software
B2B
$6.81 M
Medisafe
Active
Software
B2B, B2B2C, B2C
$51.5 M
3

Investment Rounds History

Startup

Date Announced

Funding Round

Amount Raised

Investors

Similar Investors

Jerusalem Venture Partners
TYPE
Venture Capital
14W

14W

TYPE
Venture Capital
Israel Innovation Authority
TYPE
Government
CE Ventures
TYPE
Venture Capital
Flint Capital
TYPE
Venture Capital
Merck Ventures
TYPE
Corporate Venture Capital
Arkin Holdings
TYPE
Family Office
Mangrove Capital Partners
TYPE
Venture Capital
TPY Capital
TYPE
Venture Capital
OrbiMed
TYPE
Venture Capital
MIN CHEQUE
$5.3 M
Glilot Capital Partners
TYPE
Venture Capital
Third Rock Ventures
TYPE
Venture Capital
Qualcomm Ventures
TYPE
Corporate Venture Capital
Lightspeed Venture Partners
TYPE
Venture Capital
Emerge
TYPE
Venture Capital
Technion
TYPE
University
AO Invest
TYPE
Venture Capital
Sompo Holdings
TYPE
Corporate Venture Capital
Arch Venture Partners
TYPE
Venture Capital
MIN CHEQUE
$0.05 M
Esplanade Ventures
TYPE
Venture Capital

CONTACT

Sign up for free

  • Save profiles to your list
  • View all funding rounds
  • Advanced sorting filter access
  • Search investment rounds
  • Search exit events

Sign up for Pro

  • Export lists (CSV, Excel) of startups and investors
  • View newly added AI startups
  • View investor emails
  • View investment funds and rounds sources
  • Advanced filters, sorting and search
  • Starting at just $15 per month